Désirée Sexauer
Désirée Sexauer is a PhD student at Edith Cowan University in WA, and is a recipient of a MIA Postgraduate Research Scholarship. Read her Q&A.
Dr Camelia Quek
Dr Camelia Quek is a Postdoctoral Researcher at Melanoma Institute Australia. Camelia answers our questions about her research and personal insights.
A month of inspiring Community Fundraising
Read more about the inspiring stories behind our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
Our photo tribute to Kay Van Norton Poche AO
Pictures tell a thousand words, and we are proud to share this photo tribute of Kay and her friendship with us over many years.
Vale Kay Van Norton Poche AO
It is with a heavy heart that we notify you that Kay Van Norton Poche AO, one of Melanoma Institute Australia's great friends and committed supporters, passed away on 14 June 2024, following a long illness.
Community Fundraising teamwork and tributes
Read more about the inspiring stories behind our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
We can’t thank our community fundraisers enough
Read more about the inspiring stories behind the dedication and generosity of our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
Roadmap Launch meeting – 14th March 2025
The Roadmap Launch Meeting was held at MIA on 14 March 2025. View the Summary Report of the meeting and watch recording of the meeting introduction.
Our passionate community fundraisers
Read more about the inspiring stories behind the dedication and generosity of our Community Fundraisers. Find out how you can fundraise to support melanoma research, which is also impacting other cancers.
Xinyu (Catherine) Bai
Meet Catherine, a PhD student and researcher at MIA. Catherine's current research focus is "Single Cell Spatial Features of In-Transit Melanoma Associated With Patient Outcomes To Immunotherapy".